Several studies emphasized on IRF-1 as a transcriptional activator that facilitates a Th1 immune phenotype and leads to tumor infiltration of CD8+ lymphocytes associated with a favorable prognosis in cancer patients [23,102,118]. The gene discussed is CD8A; the disease is neoplasm.